|
Name: Nimetazepam
Type: Benzodiazepine
AKA: Erimin
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Nimetazepam, a benzodiazepine, was introduced in the 1980s. It is used for its anxiolytic and hypnotic effects and has contributed to the development of benzodiazepine medications.
|
|
V. Legal Information
Nimetazepam, a benzodiazepine, is controlled as a Schedule IV substance in the US and banned in many countries due to its potential for abuse and dependency. Initially used for its sedative effects, it has seen widespread misuse, leading to stricter regulations. The UNODC notes the increasing trend towards tighter control and monitoring to prevent illegal distribution and abuse.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Nimetazepam is a benzodiazepine used for anxiety and sleep disorders. It acts as a downer, causing sedation, muscle relaxation, and reduced heart rate. Short-term use is effective for managing anxiety and insomnia, but long-term use can lead to dependence, cognitive impairment, and health issues. Overdose risks include severe sedation, respiratory depression, and potential death. Safe use involves following prescribed dosages and monitoring for side effects. Recent research explores its efficacy and risks.  |
|
VII. Psychological Effects
Nimetazepam is a benzodiazepine with sedative and anxiolytic effects. Short-term use can enhance relaxation and mood, while long-term use may lead to cognitive impairments, dependence, and mood disturbances. Research highlights its impact on GABAergic systems.
 |
|
VIII. Culture
Nimetazepam, a benzodiazepine derivative, is known for its sedative and anxiolytic effects, classifying it as a downer. It induces muscle relaxation, sleepiness, and can reduce anxiety. Short-term use may impair coordination and cognitive functions, while long-term use can lead to dependence and withdrawal symptoms. Overdose is possible and can be fatal, often causing respiratory depression and coma. Safe usage involves strict adherence to prescribed dosages, generally not exceeding 5-10 mg per day. Recent research highlights risks of dependency and emphasizes caution in prescribing. Physical signs of use include drowsiness and slowed reflexes.
 |